Find More Contacts for Morphic Therapeutic
Protected Content
Chairman
Director, Executive Management
1 email found 2 phone numbers found
View contacts for Morphic Therapeutic to access new leads and connect with decision-makers.
View All Contacts

Details

Edit Details Section
  • Contact Email info@morphictx.com
  • Phone Number (781)996-0955

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. The company offers the development of therapies for patients with immunological, fibrotic, neoplastic, and vascular diseases, focusing on creating

small molecule inhibitors of various integrin targets.

Lists Featuring This Company

Edit Lists Featuring This Company Section
Health Care Companies With More Than $50M in Revenue (Top 10K)
9,948 Number of Organizations • $624B Total Funding Amount • 8,325 Number of Investors
United States Companies With More Than $1M in Revenue (Top 10K)
9,932 Number of Organizations • $3.3T Total Funding Amount • 92,976 Number of Investors
Acquired Health Care Companies (Top 10K)
9,896 Number of Organizations • $242.2B Total Funding Amount • 15,404 Number of Investors
Health Care Companies With More Than 100 Employees (Top 10K)
9,824 Number of Organizations • $884.5B Total Funding Amount • 23,937 Number of Investors

M&A Details

Edit M&A Details Section
Morphic Therapeutic was acquired by Eli Lilly for $3.2B on Jul 8, 2024. This deal was done in Cash.

Frequently Asked Questions

Edit Frequently Asked Questions Section
Where is Morphic Therapeutic's headquarters? Morphic Therapeutic is located in Waltham, Massachusetts, United States.Who invested in Morphic Therapeutic? Morphic Therapeutic has 11 investors including Pfizer Venture Investments and Novo Holdings.How much funding has Morphic Therapeutic raised to date? Morphic Therapeutic has raised
$510.5M
.When was the last funding round for Morphic Therapeutic? Morphic Therapeutic closed its last funding round on May 3, 2023 from a Post-IPO Equity round.Who are Morphic Therapeutic's competitors? Alternatives and possible competitors to Morphic Therapeutic may include Interius BioTherapeutics, Gritstone bio, and Georgiamune.